Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 27,690	$ 52,100
Short-term investments	140,561	73,776
Prepaid expenses and other current assets	1,845	3,078
Total current assets	170,096	128,954
Property and equipment, net	277	51
In-process R&D	10,497	10,656
Other non-current assets	1,202	116
Total assets	182,072	139,777
Current liabilities:
Accounts payable	3,219	1,334
Accrued expenses and other current liabilities	5,744	4,533
Total current liabilities	8,963	5,867
Long-term liabilities:
Long-term debt	26,281	26,078
Other long-term liabilities	284	54
Total liabilities	35,528	31,999
Commitments and Contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.001 par value, 300,000,000 authorized as of September 30, 2023 and December 31, 2022; 135,339,836 and 114,046,345 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	137	116
Additional paid-in capital	524,619	446,938
Accumulated other comprehensive loss	(942)	(605)
Accumulated deficit	(377,270)	(338,671)
Total stockholders’ equity	146,544	107,778
Total liabilities and stockholders’ equity	$ 182,072	$ 139,777